Li X - Search Results

1

Nuclear-targeted chimeric peptide nanorods to amplify innate anti-tumor immunity through localized DNA damage and STING activation.

Wu Y, Li Y, Yan N, Huang J, Li X, Zhang K, Lu Z, Qiu Z, Cheng H. Wu Y, et al. Among authors: li y, li x. J Control Release. 2024 May;369:531-544. doi: 10.1016/j.jconrel.2024.04.008. Epub 2024 Apr 9. J Control Release. 2024. PMID: 38580138

2

Carrier Free Photodynamic Synergists for Oxidative Damage Amplified Tumor Therapy.

Li XY, Deng FA, Zheng RR, Liu LS, Liu YB, Kong RJ, Chen AL, Yu XY, Li SY, Cheng H. Li XY, et al. Small. 2021 Oct;17(40):e2102470. doi: 10.1002/smll.202102470. Epub 2021 Sep 4. Small. 2021. PMID: 34480417

3

Carrier-free nanomedicine for enhanced photodynamic tumor therapy through glutathione S-transferase inhibition.

Li X, Kong R, Li Y, Huang J, Zhou X, Li S, Cheng H. Li X, et al. Among authors: li s, li y. Chem Commun (Camb). 2022 Mar 22;58(24):3917-3920. doi: 10.1039/d2cc00235c. Chem Commun (Camb). 2022. PMID: 35237781

4

Carrier free nanomedicine to reverse anti-apoptosis and elevate endoplasmic reticulum stress for enhanced photodynamic therapy.

Zhou X, Li Y, Li X, Huang J, Kong R, Liu L, Cheng H. Zhou X, et al. Among authors: li y, li x. Acta Biomater. 2022 Oct 15;152:507-518. doi: 10.1016/j.actbio.2022.08.045. Epub 2022 Aug 25. Acta Biomater. 2022. PMID: 36030050

5

A self-delivery photodynamic sensitizer for enhanced DNA damage by PARP inhibition.

Kong RJ, Li XY, Huang JQ, Zhou X, Deng FA, Li YM, Liu LS, Li SY, Cheng H. Kong RJ, et al. Among authors: li ym, li xy, li sy. Biomater Sci. 2022 Dec 20;11(1):162-169. doi: 10.1039/d2bm01320g. Biomater Sci. 2022. PMID: 36398488

6

Feedback-Elevated Antitumor Amplifier of Self-Delivery Nanomedicine by Suppressing Photodynamic Therapy-Caused Inflammation.

Li XY, Li YM, Kong RJ, Yan N, Zhou X, Huang JQ, Wang T, Li SY, Cheng H. Li XY, et al. Among authors: li ym, li sy. ACS Appl Bio Mater. 2023 Jul 17;6(7):2816-2825. doi: 10.1021/acsabm.3c00263. Epub 2023 Jun 16. ACS Appl Bio Mater. 2023. PMID: 37326439

7

Neuropilin-1-Targeted Nanomedicine for Spatiotemporal Tumor Suppression through Photodynamic Vascular Damage and Antiangiogenesis.

Li XY, Yan N, Wu YY, Kong RJ, Qiu ZW, Liu SP, Wu DH, Cheng H. Li XY, et al. ACS Appl Mater Interfaces. 2024 May 1;16(17):21709-21721. doi: 10.1021/acsami.4c03886. Epub 2024 Apr 23. ACS Appl Mater Interfaces. 2024. PMID: 38651381

8

Mitochondria-Targeted Degradable Nanocomposite Combined with Laser and Ultrasound for Synergistic Tumor Therapies.

Zhu S, Wang DQ, Sun XH, Li XY, Xiao HF, Sun WR, Wang XT, Li YJ, Wang PY, Xie SY, Wang RR. Zhu S, et al. J Biomed Nanotechnol. 2022 Mar 1;18(3):763-777. doi: 10.1166/jbn.2022.3287. J Biomed Nanotechnol. 2022. PMID: 35715902

9

Bioengineered Bacterial Membrane Vesicles with Multifunctional Nanoparticles as a Versatile Platform for Cancer Immunotherapy.

Liu XZ, Wen ZJ, Li YM, Sun WR, Hu XQ, Zhu JZ, Li XY, Wang PY, Pedraz JL, Lee JH, Kim HW, Ramalingam M, Xie S, Wang R. Liu XZ, et al. ACS Appl Mater Interfaces. 2023 Jan 25;15(3):3744-3759. doi: 10.1021/acsami.2c18244. Epub 2023 Jan 11. ACS Appl Mater Interfaces. 2023. PMID: 36630299

10

Molecularly Stimuli-Responsive Self-Assembled Peptide Nanoparticles for Targeted Imaging and Therapy.

Zhou Y, Li Q, Wu Y, Li X, Zhou Y, Wang Z, Liang H, Ding F, Hong S, Steinmetz NF, Cai H. Zhou Y, et al. Among authors: li x, li q. ACS Nano. 2023 May 9;17(9):8004-8025. doi: 10.1021/acsnano.3c01452. Epub 2023 Apr 20. ACS Nano. 2023. PMID: 37079378 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

179,856 results

Search Page

Filters